Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNZ-2566 (Trofinetide) in Traumatic Brain Injury
NCT00805818Phase 2Completed
- Sponsor
- Neuren Pharmaceuticals Limited
- Start
- Apr 2010
- Primary completion
- Jan 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trofinetide in traumatic brain injury (TBI), sponsored by Neuren Pharmaceuticals Limited. Started Apr 2010; status: completed.
02
Drugs
trofinetide
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT00805818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805818.